NEW YORK – Two different research groups have developed new CRISPR-based diagnostic assays for the SARS-CoV-2 virus that can be read with smartphones, and can quantitatively measure patients' viral loads in addition to testing for infection.
NEW YORK – Two different research groups have developed new CRISPR-based diagnostic assays for the SARS-CoV-2 virus that can be read with smartphones, and can quantitatively measure patients' viral loads in addition to testing for infection.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.